Citations

Showing 10 of 108104 citations.

Glycine decarboxylase deficiency–induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level
Riché, Raphaëlle , Liao, Meijiang , Leung, Kit‐Yi , Lepage, Nathalie , Greene, Nicolas D.E., Sarafoglou, Kyriakie , Schimmenti, Lisa A. , Samarut, Éric , Schimmenti, Lisa A , Pena, Izabella Agostinho , Drapeau, Pierre

Mayo Clinic

JCI Insight | October 23, 2018 | Volume: 3 | Issue: 21 | Pages: No page available

10.1172/jci.insight.124642 | PMID 30385710 Get It

Glycine encephalopathy (GE), or nonketotic hyperglycinemia (NKH), is a rare recessive genetic disease caused by defective glycine cleavage and characterized by increased accumulation of glycine in all tissues. Here, based on new case reports of GLDC loss-of-function mutations in GE patients, we aimed to generate a zebrafish model of severe GE in order to unravel the molecular mechanism of the disease. Using CRISPR/Cas9, we knocked out the gldc gene and showed that gldc –/– fish recapitulate GE on a molecular level and present a motor phenotype reminiscent of severe GE symptoms. The molecular characterization of gldc –/– mutants showed a broad metabolic disturbance affecting amino acids and neurotransmitters other than glycine, with lactic acidosis at stages preceding death. Although a transient imbalance was found in cell proliferation in the brain of gldc –/– zebrafish, the main brain networks were not affected, thus suggesting that GE pathogenicity is mainly due to metabolic defects. We confirmed that the gldc –/– hypotonic phenotype is due to NMDA and glycine receptor overactivation, and demonstrated that gldc –/– larvae depict exacerbated hyperglycinemia at these synapses. Remarkably, we were able to rescue the motor dysfunction of gldc –/– larvae by counterbalancing pharmacologically or genetically the level of glycine at the synapse.
Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy
Vidal‐Folch, Noemi, Gavrilov, Dimitar , Raymond, Kimiyo , Rinaldo, Piero, Tortorelli, Silvia , Matern, Dietrich , Oglesbee, Devin , Oglesbee, Devin

Mayo Clinic

Clinical Chemistry | October 23, 2018 | Volume: 64 | Issue: 12 | Pages: 1753-1761

10.1373/clinchem.2018.293712 | PMID 30352867 Get It

Abstract BACKGROUND Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder with neuronal degeneration leading to muscular atrophy and respiratory failure. SMA is frequently caused by homozygous deletions that include exon 7 of the survival motor neuron gene SMN1, and its clinical course is influenced by the copy number of a nearby 5q SMN1 paralog, SMN2. Multiple ligation probe amplification (MLPA) and real-time quantitative PCR (qPCR) can detect SMN1 deletions. Yet, qPCR needs normalization or standard curves, and MLPA demands DNA concentrations above those obtainable from dried blood spots (DBSs). We developed a multiplex, droplet digital PCR (ddPCR) method for the simultaneous detection of SMN1 deletions and SMN2 copy number variation in DBS and other tissues. An SMN1 Sanger sequencing process for DBS was also developed. METHODS SMN1, SMN2, and RPP30 concentrations were simultaneously measured with a Bio-Rad AutoDG and QX200 ddPCR system. A total of 1530 DBSs and 12 SMA patients were tested. RESULTS Population studies confirmed 1 to 5 SMN1 exon 7 copies detected in unaffected specimens, whereas patients with SMA revealed 0 SMN1 copies. Intraassay and interassay imprecisions were <7.1% CV for individuals with ≥1 SMN1 copies. Testing 12 SMA-positive samples resulted in 100% sensitivity and specificity. CONCLUSIONS This ddPCR method is sensitive, specific, and applicable to newborn screening and carrier status determination for SMA. It can also be incorporated with a parallel ddPCR T-cell excision circles assay for severe combined immunodeficiencies.
Smooth muscle brain‐derived neurotrophic factor contributes to airway hyperreactivity in a mouse model of allergic asthma
Britt, Rodney D. , Wicher, Sarah A. , Manlove, L., Roesler, A.M., Fang, Yun-Hua, Roos, Carolyn M, Miller, Jordan D. , Prakash, Y. S. , Manlove, Logan J, Roesler, Anne, Roos, Carolyn, Prakash, Y S , Thompson, Michael A. , Smith, Leslie , Pabelick, Christina M. , Miller, Jordan

Mayo Clinic

The FASEB Journal | October 23, 2018 | Volume: 33 | Issue: 2 | Pages: 3024-3034

10.1096/fj.201801002r | PMID 30351991 Get It

ABSTRACT Recent studies have demonstrated an effect of neurotrophins, particularly brain‐derived neurotrophic factor (BDNF), on airway contractility [ via increased airway smooth muscle (ASM) intracellular calcium [Ca 2+ ] i ] and remodeling (ASM proliferation and extracellular matrix formation) in the context of airway disease. In the present study, we examined the role of BDNF in allergen‐induced airway inflammation using 2 transgenic models: 1 ) tropomyosin‐related kinase B (TrkB) conditional knockin (TrkBKI) mice allowing for inducible, reversible disruption of BDNF receptor kinase activity by administration of 1NMPP1, a PP1 derivative, and 2) smooth muscle‐specific BDNF knockout (BDNF fl/fl /SMMHCll Cre/0 ) mice. Adult mice were intranasally challenged with PBS or mixed allergen ( Altemaria alternata, Aspergillus fumigatus , house dust mite, and ovalbumin) for 4 wk. Our data show that administration of 1NMPP1 in TrkBKI mice during the 4‐wk allergen challenge blunted airway hyper‐responsiveness (AHR) and reduced fibronectin mRNA expression in ASM layers but did not reduce inflammation per se . Smooth muscle‐specific deletion of BDNF reduced AHR and blunted airway fibrosis but did not significantly alter airway inflammation. Together, our novel data indicate that TrkB signaling is a key modulator of AHR and that smooth muscle‐derived BDNF mediates these effects during allergic airway inflammation.—Britt, R. D., Jr., Thompson, M. A., Wicher, S. A., Manlove, L. J., Roesler, A., Fang, Y.‐H., Roos, C., Smith, L., Miller, J. D., Pabelick, C. M., Prakash, Y. S. Smooth muscle brain‐derived neurotrophic factor contributes to airway hyperreactivity in a mouse model of allergic asthma. FASEB J. 33, 3024–3034 (2019). www.fasebj.org
Transcatheter aortic valve replacement in patients with pure native aortic valve regurgitation: A systematic review and meta‐analysis
Haddad, Abdullah , Arwani, Remy, Altayar, Osama , Sawas, Tarek , Murad, M. Hassan , Marchena, Eduardo de , Murad, M Hassan , Altayar, Osama

Mayo Clinic

Clinical Cardiology | October 23, 2018 | Volume: 42 | Issue: 1 | Pages: 159-166

10.1002/clc.23103 | PMID 30350358 Get It

This systematic review and meta‐analysis sought to summarize the available evidence on the use of transcatheter aortic valve replacement (TAVR) in patients with Native Aortic Valve Regurgitation (NAVR) and compare outcomes between first and second generation valves. Owing to the improvements in transcatheter heart valve design and procedural success, TAVR has become increasingly performed in broader aortic valve pathologies. We searched Medline, Embase, Cochrane, and Scopus databases from 2007 to 2018 and performed a systematic review on reports with at least 10 patients with aortic valve regurgitation undergoing TAVR procedure. The main outcome of interest was all‐cause mortality at 30 days. A total of 638 patients across 12 studies were included. Mean age ranged from 68 to 84. Society of Thoracic Surgeons score ranged from 5.4% to 13.1% and Logistic EuroSCORE ranged from 18.2% to 33%. The incidence rate of all‐cause mortality at 30 days was found to be 11% (95% CI 7%‐16%; I2 = 20.86%). All‐cause mortality at 30 days for first generation valves had an incidence rate of 15% (95% CI 10%‐20%; I2 = 10%) compared to 7% (95% CI 3%‐13%; I2 = 37%) in second generation valves with subgroup interaction analysis P = 0.059. Device success incidence rate in second generation valves was 92% (95% CI 83%‐99%; I2 = 67%) vs 68% (95% CI 59%‐77%; I2 = 53%) in first generation valves with P = 0.001. TAVR appears to be a feasible treatment choice for NAVR patients at high risk for surgical valve replacement. Second generation valves show promising results in terms of short‐term outcomes.
Exploring the spatiotemporal genetic heterogeneity in metastatic lung adenocarcinoma using a nuclei flow‐sorting approach
Lorber, Thomas , Andor, Noemi , Dietsche, Tanja, Perrina, Valeria, Juškevičius, Darius , Pereira, K. V. M, Greer, Stephanie , Krause, Arthur, Müller, David C. , Prince, Spasenija Savic , Lardinois, Didier , Barrett, Michael T. , Bubendorf, Lukas , Ruiz, Christian Felipe , Bubendorf, Lukas

Mayo Clinic

The Journal of Pathology | October 23, 2018 | Volume: 247 | Issue: 2 | Pages: 199-213

10.1002/path.5183 | PMID 30350422 Get It

AbstractVariable tumor cellularity can limit sensitivity and precision in comparative genomics because differences in tumor content can result in misclassifying truncal mutations as region‐specific private mutations in stroma‐rich regions, especially when studying tissue specimens of mediocre tumor cellularity such as lung adenocarcinomas (LUADs). To address this issue, we refined a nuclei flow‐sorting approach by sorting nuclei based on ploidy and the LUAD lineage marker thyroid transcription factor 1 and applied this method to investigate genome‐wide somatic copy number aberrations (SCNAs) and mutations of 409 cancer genes in 39 tumor populations obtained from 16 primary tumors and 21 matched metastases. This approach increased the mean tumor purity from 54% (range 7–89%) of unsorted material to 92% (range 79–99%) after sorting. Despite this rise in tumor purity, we detected limited genetic heterogeneity between primary tumors and their metastases. In fact, 88% of SCNAs and 80% of mutations were propagated from primary tumors to metastases and low allele frequency mutations accounted for much of the mutational heterogeneity. Even though the presence of SCNAs indicated a history of chromosomal instability (CIN) in all tumors, metastases did not have more SCNAs than primary tumors. Moreover, tumors with biallelic TP53 or ATM mutations had high numbers of SCNAs, yet they were associated with a low interlesional genetic heterogeneity. The results of our study thus provide evidence that most macroevolutionary events occur in primary tumors before metastatic dissemination and advocate for a limited degree of CIN over time and space in this cohort of LUADs. Sampling of primary tumors thus may suffice to detect most mutations and SCNAs. In addition, metastases but not primary tumors had seeded additional metastases in three of four patients; this provides a genomic rational for surgical treatment of such oligometastatic LUADs. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Early Implant Failure Associated With Patient Factors, Surgical Manipulations, and Systemic Conditions
Arwani, Noura, Lohse, Christine M. , Gonzalez, Ricardo L. Vidal, Muller, Olivia M. , Salinas, Thomas , Carr, Alan B. , Salinas, Thomas J

Mayo Clinic

Journal of Prosthodontics | October 23, 2018 | Volume: 28 | Issue: 6 | Pages: 623-633

10.1111/jopr.12978 | PMID 30350385 Get It

Abstract Purpose Systematic monitoring of important clinical outcomes is increasingly important for health‐care decision making, especially in the context of continuous quality improvement. Dental implant failure within the first year (early failure) has been previously shown to be more common than subsequent failure. The purpose of this study was to identify associations between early implant failure and patient factors, surgical manipulations, and systemic conditions. Materials and Methods The authors retrospectively identified the records of consecutive adult patients with dental implants seen between 2000 and 2014 in the Department of Dental Specialties, at the Mayo Clinic. Demographic, surgical, and medical data were extracted from the database and individual medical records to determine time to first implant failure. Cox proportional hazards regression models were used to assess associations of demographic, surgical, and systemic conditions with implant failure during the first year post‐implantation, summarized as hazard ratio (HR) (95% confidence interval [CI]). Results Among 8540 implants identified during the study period, 362 (4.2%) failed within the first year of placement at a mean (SD) of 129 (96) days after placement. On univariate analysis, most candidate predictors were not shown to influence first‐year failure. Preplacement surgical manipulations associated with increased early implant failure were bone augmentation only (HR, 1.45; 95% CI, 1.02‐2.05; p = 0.04), socket preservation (HR, 2.67; 95% CI, 1.33‐5.38; p = 0.006), and xenogenic material (HR, 2.12; 95% CI, 1.11‐4.04; p = 0.02). Alveoloplasty only at placement was associated with decreased early implant failure (HR, 0.33; 95% CI, 0.17‐0.65; p = 0.001). Overall, 318 implants (3.7%) had surgical complications within the first year of placement at a mean (SD) of 110 (114) days after placement; any surgical complication was significantly associated with early implant failure (hazard ratio, 15.84; 95% CI, 11.10‐22.61; p < 0.001). After adjustment for age, sex, and implant era, no single or multiple medical condition(s) and no single or multiple medication(s) increased patient risk of implant failure in the first year after placement. Conclusions These findings support a targeted effort to reduce the incidence of surgical complications to reduce early failure of dental implants.
An update on Mycobacterium tuberculosis infection after hematopoietic stem cell transplantation in adults
Abad, Cybéle Lara R. , Razonable, Raymund R.

Mayo Clinic

Clinical Transplantation | October 22, 2018 | Volume: 32 | Issue: 12 | Pages: No page available

10.1111/ctr.13430 | PMID 30347465 Get It

AbstractBackgroundMycobacterium tuberculosis (TB) is common worldwide, but is rarely reported after hematopoietic transplantation (HSCT). We reviewed all TB cases among HSCT since 2010 to provide an update on its epidemiology, clinical presentation, management and outcome.MethodsSeveral databases were reviewed from January 1, 2010 to June 30, 2018 using key words tuberculosis and hematopoietic transplantation.ResultsThe 47 cases of TB were reported during the study period. The highest TB frequency was reported from India (2.9%), with a median frequency of 2% (range, 0.18%‐2.9%). The majority were recipients of allogeneic transplants (45/47, 95.7%). Pulmonary TB was the most common clinical presentation (20/47, 42.6%). The median time to clinical presentation was 4.6 (range, 3‐12.9) and 2.4 (range, 0.6‐5) months, based on cohort data and case reports, respectively. Fever was reported in 87.5% (14/16) of patients. First‐line quadruple drug therapy was frequently used (29/35, 82.9%), with a median length of 12 and 9 months for cohorts and case reports, respectively. All‐cause and attributable mortality was 27.6% (13/47), and 8.5% (4/47), respectively.ConclusionsMycobacterium tuberculosis presents early after HSCT, most commonly as fever. A high index of suspicion is needed for early diagnosis and treatment, to prevent TB‐attributable mortality.
Mitochondrial ADP Sensitivity and Transport: New Insights Into Diet-Induced Mitochondrial Impairments
Hart, Corey R., Lanza, Ian R. , Lanza, Ian R

Mayo Clinic

Diabetes | October 22, 2018 | Volume: 67 | Issue: 11 | Pages: 2152-2153

10.2337/dbi18-0030 | PMID 30348821 Get It

MRI review of female pelvic fistulizing disease
Hyde, Brenda , Byrnes, Jenifer N., Occhino, John A. , Sheedy, Shannon P. , VanBuren, Wendaline M. , Hyde, Brenda J

Mayo Clinic

Journal of Magnetic Resonance Imaging | October 22, 2018 | Volume: 48 | Issue: 5 | Pages: 1172-1184

10.1002/jmri.26248 | PMID 30347131 Get It

A wide variety of fistulae occur in the female pelvis, most of which cause significant morbidity. Diagnosis, characterization, and treatment planning may be difficult using traditional imaging modalities such as fluoroscopy and computed tomography. To date, there is no comprehensive literature review of the radiologic findings associated with various types of female pelvic fistulae, and furthermore, none dedicated to magnetic resonance imaging (MRI). In this article, we seek to provide a broad overview of the MRI characteristics of female pelvic fistulizing disease in combination with epidemiologic and clinical characteristics. MRI is often considered the imaging modality of choice for evaluation of fistulae owing to its superior soft‐tissue contrast and ability to provide surgeons with the highest quality information derived from just one study, including anatomic location of fistulae and associated pelvic pathology. In other instances, MRI can be complementary to the more traditional imaging techniques. This review will describe the etiology, anatomy, MRI findings, and treatment pearls for several of the more common pelvic fistulae found in female patients, including anovaginal, rectovaginal, colovaginal, vesicovaginal, colovesical, and other complex fistulae.Level of Evidence: 5Technical Efficacy: Stage 3J. Magn. Reson. Imaging 2018;47:1172–1184
Recommendation for terminology: Nodules without arterial phase hyperenhancement and with hepatobiliary phase hypointensity in chronic liver disease
Murakami, Takamichi , Lee, Jeong Min , Heiken, Jay P. , Group, for the LI‐RADS HBA Working, Motosugi, Utaroh , Fowler, Kathryn J. , Sirlin, Claude B. , Group, for the LI‐RADS HBA Working

Mayo Clinic

Journal of Magnetic Resonance Imaging | October 22, 2018 | Volume: 48 | Issue: 5 | Pages: 1169-1171

10.1002/jmri.26515 | PMID 30347132 Get It

Level of Evidence : 5 Technical Efficacy Stage : 3 J. Magn. Reson. Imaging 2018;47:1169–1171.